eicosapentaenoic acid ethyl ester has been researched along with Alloxan Diabetes in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study examined the effects of eicosapentaenoic acid (EPA) administration on the prevention of early hearing loss in diabetic mice." | 8.31 | Prevention of progressive hearing loss in a mouse model of diabetes by oral intake of eicosapentaenoic acid ethyl ester. ( Hashimoto, M; Matsuura, T; Sugahara, K; Tsuda, J; Yamamoto, Y; Yamashita, H, 2023) |
| "This study examined the effects of eicosapentaenoic acid (EPA) administration on the prevention of early hearing loss in diabetic mice." | 4.31 | Prevention of progressive hearing loss in a mouse model of diabetes by oral intake of eicosapentaenoic acid ethyl ester. ( Hashimoto, M; Matsuura, T; Sugahara, K; Tsuda, J; Yamamoto, Y; Yamashita, H, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuura, T | 1 |
| Sugahara, K | 1 |
| Yamamoto, Y | 1 |
| Tsuda, J | 1 |
| Hashimoto, M | 1 |
| Yamashita, H | 1 |
| Takenouchi, Y | 1 |
| Ohtake, K | 1 |
| Nobe, K | 1 |
| Kasono, K | 1 |
| Fujikawa, M | 2 |
| Yamazaki, K | 2 |
| Hamazaki, T | 2 |
| Wakaki, K | 1 |
| Koizumi, F | 1 |
| Yano, S | 2 |
| Kobayashi, M | 1 |
| Sawazaki, S | 1 |
| Taki, H | 1 |
| Kaneda, M | 1 |
| Urakaze, M | 1 |
| Fujita, T | 1 |
4 other studies available for eicosapentaenoic acid ethyl ester and Alloxan Diabetes
| Article | Year |
|---|---|
Prevention of progressive hearing loss in a mouse model of diabetes by oral intake of eicosapentaenoic acid ethyl ester.
Topics: Animals; Cochlea; Deafness; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Mode | 2023 |
Eicosapentaenoic acid ethyl ester improves endothelial dysfunction in type 2 diabetic mice.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Blood Glucose; Cardiovascular Agents; Cholesterol; Diabetes | 2018 |
Effect of eicosapentaenoic acid ethyl ester on albuminuria in streptozotocin-induced diabetic rats.
Topics: 6-Ketoprostaglandin F1 alpha; Albuminuria; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus | 1994 |
Effect of eicosapentaenoic acid ethyl ester on proteinuria of streptozotocin-induced diabetes mellitus in rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dietary Fats; Eicosapentaenoic | 1989 |